INS and metabolic dysfunction-associated steatotic liver disease: Of note, insulin sensitizers such as thiazolidinediones (TZDs), glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase 4 inhibitors have been studied as therapeutic approaches for NAFLD in recent years and have been shown to have some beneficial effects45.